retatrutide trial results october 2025 New Phase 3 data just dropped 👀 Eli Lilly's reported average weight loss approaching 30%, with some patients achieving historically associated with bariatric surgery. A few important caveats Triple hormone receptor agonist retatrutide

Weight Loss but Mixed Results With Victoza and Ozempic Victoza helped me lose a bunch of weight with no side effects

Individuals with a history of failed weight loss attempts and those committed to long-term lifestyle changes are the best candidates for this therapy

However, the inhibitory potency of these natural compounds remains orders of magnitude below pharmaceutical DPP-4 inhibitors

Combination arms with Wegovy introduce familiar operational complexitiesdual drug supply, synchronized titration, and adherence managementbut may be offset by clearer patient demand if the regimen promises efficacy with fewer GI burdens